TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bionomen AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
17,272
|
8,412
|
7,734 |
| Financial expenses |
6
|
6
|
9 |
| Earnings before taxes |
3,095
|
1,068
|
-49 |
| EBITDA |
3,101
|
1,079
|
-34 |
| Total assets |
5,109
|
3,060
|
4,922 |
| Current assets |
5,078
|
3,021
|
4,907 |
| Current liabilities |
1,042
|
1,689
|
1,842 |
| Equity capital |
3,799
|
1,267
|
2,972 |
| - share capital |
51
|
47
|
49 |
| Employees (average) |
2
|
2
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
74.4%
|
41.4%
|
60.4% |
| Turnover per employee |
8,636
|
4,206
|
2,578 |
| Profit as a percentage of turnover |
17.9%
|
12.7%
|
-0.6% |
| Return on assets (ROA) |
60.7%
|
35.1%
|
-0.8% |
| Current ratio |
487.3%
|
178.9%
|
266.4% |
| Return on equity (ROE) |
81.5%
|
84.3%
|
-1.6% |
| Change turnover |
8,263
|
910
|
474 |
| Change turnover % |
92%
|
12%
|
7% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-33%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.